Chindo Hicks, Ph.D., Associate Professor
Director, Cancer Bioinformatics, Cancer Institute
Associate Director, Center for Biostatistics and Bioinformatics
University of Mississippi Medical Center
To be presented Friday, April 29, 2011, from 2:30 pm to 3:30 pm in the Overby Center Auditorium on the Oxford campus of the University of Mississippi.
The entire UM community is invited to this presentation.
Students interested in biomedical research opportunities are especially encouraged to attend.
Reservations are not required for the lecture. However, individuals interested in scheduling one-on-one meetings to discuss research/collaboration opportunities with Dr. Hicks Friday morning should e-mail Jason Hale at jghale ( at ) olemiss ( dot) edu to make a reservation.
The genomics revolution that includes the Human Genome Project, high-throughput genotyping, next generation sequencing, whole-genome gene expression, protein and metabolomic profiling and other biotechnology breakthroughs are having a remarkable impact on biomedical research. As the Human Genome Project continues to decipher the secrets of our genetic makeup, biomedical researchers around the world are gaining insights about the genetic landscape of common human diseases. To achieve the promise of a new era in biomedicine and to deliver care that is personalized, predictive, preemptive, and patient-centered, we must capture, analyze and integrate huge amounts of biological and clinical data, disseminate it widely, and continually transform it into liquidity and knowledge. In this talk we shall present and discuss a novel integrative genomics approach to biomarker discovery in breast cancer. Key to this approach is integration of genotype data with gene expression data to identify targets and biological pathways for early therapeutic interventions in breast cancer.